baber/WOPTO huggingface dataset:
Patent FI-20011209-A0 (FI)
Inventor: SILVENTOINEN MARKO
IPC: H04L12/58
Filed: 2001-06-07
Abstract: A method of transmitting messages with text-mode contents in a telecommunication system, and a telecommunication system comprising means (10, 20) for transmitting messages with text-mode contents from a sender (MS, PC) to a receiver (MS, PC), a database (DB) containing at least one first character string (STRING1) containing at least one character, and at least one corresponding second character string (STRING2) containing at least one character, and message-editing means (SMSC) adapted to replace each second character string according to the database in the textual contents of the message with a corresponding first character string before the message is delivered to the receiver. <IMAGE>
Patent FI-20022006-A0 (FI)
Inventor: FABRITIUS SAMPSA
IPC: G06F1/32
Filed: 2002-11-08
Abstract: An arrangement for collecting operational information on a closed system. The collecting system comprises an instrument to be connected functionally to a monitorable component of the closed system and a data collector comprising a register. The instrument collects operational information on the component that is transmitted onward to the data collector. The operational information is stored in the register. The collecting system can also comprise an analyzing module that determines the performance and/or power consumption of the closed system on the basis of the received operational information. The col-lecting system can also comprise a controlling module comprising a control algorithm and being functionally connected to the analyzing module for adjust-ing the performance or power consumption of the closed system on the basis of analysis information.
Patent FI-20030427-A0 (FI)
Inventor: KIVIRANTA VELI-MATTI
IPC: H04W24/00
Filed: 2003-03-24
Abstract: A location of a subscriber can be observed by means of a mobile network in a completely anonymous way, without a subscriber identifier or a temporary subscriber identifier. At first, a method extracts from a first time slot of a radio channel a message which includes information about a second time slot of a radio channel. The first time slot of a radio channel discloses the current cell of the subscriber and the second time slot of a radio channel discloses a new cell of the subscriber. A location of the subscriber is determined on the basis of the current and the new cell. This location is approximately situated in a geographical intersection area of the current and the new cell. Different kinds of statistics can be deduced from the observations concerning activities of subscribers.
Patent FI-20115591-A0 (FI)
Inventor: PAULASAARI JYRI
IPC: C07C/
Filed: 2011-06-14
Abstract: A method for preparation and polymerization of siloxane monomers of Formula I is presented. The synthesis includes the selective reaction between silanol containing unit and alkoxy containing units in the presence of basic catalyst. The siloxane monomers of the invention can be used for preparation of siloxane polymers with good flexibility and cracking threshold, and functional sites, useful for applications requiring low metal content in semiconductor industry.
Patent IL-108324-A0 (IL)
Title: Particle reinforced ceramic cutting tool material
IPC: C04B35/80
Filed: 1994-01-12
Abstract: According to the present invention there is now provided a ceramic cutting tool material comprising an oxide-based, preferably aluminium oxide based, matrix with 5-50, preferably 10-40 % by volume of homogeneously dispersed whiskers based upon nitrides, carbides and/or borides of metals from group IVB (Ti,Zr,Hf) and/or VB(V,Nb,Ta) in the periodic system or solid solutions thereof and 1-20, preferably 3-8 % by volume of particulate additions with a size < 500 nm, preferably < 200 nm, based upon carbides, nitrides and/or borides of metals from group IVB (Ti,Zr,Hf) and/or VB(V,Nb,Ta) in the periodic system or solid solutions thereof. The nanosize particulate additions are predominantly present inside the matrix grains and not in the grain boundaries.
Patent IL-109944-A0 (IL)
Title: Sustained release compositions and a method of preparing pharmaceutical compositions
IPC: A61K31/485
Filed: 1994-06-08
Abstract: In order to provide a sustained release pharmaceutical formulation containing morphine which is suitable for administration on a once daily basis, in a first aspect, an orally administrable sustained release dosage unit form contains morphine, or a pharmaceutically acceptable salt thereof, as active ingredient, which formulation gives a peak plasma level at 1.0 to 6 hours after administration. In a second aspect, the formulation contains an effective amount of morphine or a pharmaceutically acceptable salt thereof, characterised by a W50 for the M-6-G metabolite or for morphine of between 4 and 12 hours. In a third aspect, the pharmaceutical dosage unit form is obtainable by compressing multiparticulates comprising a pharmaceutically active substance in a matrix of hydrophobic fusible material having a melting point of from 35 to 150 DEG C, the dosage form optionally containing conventional tabletting excipients. In a further aspect of the invention, sustained release multiparticulates containing morphine or a pharmaceutically acceptable salt thereof are produced by mechanically working in a high-speed mixer a mixture of particulate morphine or a pharmaceutically acceptable salt thereof and a particulate, hydrophobic fusible carrier or diluent having a melting point from 35 to 150 DEG C and optionally a release control component comprising a water soluble fusible material or a particulate soluble or insoluble organic or inorganic material at a speed and energy input which allows the carrier or diluent to melt or soften whereby it agglomerates, and breaking down the agglomerates to give controlled release particles.
Patent IL-111995-A0 (IL)
Title: Methods of treating menstrual symptoms and compositions therefor
IPC: A61K31/4535
Filed: 1994-12-15
Abstract: The present invention provides a method of alleviating one or more menstrual symptoms in a woman comprising administering to said woman in need of treatment an effective amount of a compound having the formula <CHEM> wherein R<1> and R<3> are independently hydrogen, -CH3, -CO-(C1-C6 alkyl), or -CO-Ar in which Ar is optionally substituted phenyl; and R<2> is selected from the group consisting of pyrrolidino, hexamethyleneimino and piperidino; or a pharmaceutically acceptable salt or solvate thereof. The present invention also provides the aforementioned method and further comprises administering to said woman an effective amount of at least one pharmaceutical agent selected from the group consisting of an analgesic, a diuretic, and an antihistamine, and compositions therefore.
Patent IL-124378-A0 (IL)
Title: Device for coating disc-shaped data storage media
IPC: B05D1/26
Filed: 1997-03-26
Abstract: In a method for coating of disc-shaped data storage media with a coating medium at least one coating nozzle is moved quickly by a first movement into the vicinity of a coating medium application location at the inner area of a storage medium and subsequently the at least one application nozzle is moved slowly by a second movement to the location of application. The coating medium is applied at the location of application and is distributed by a centrifugal force resulting from rotation of the storage medium. The device for coating disc-shaped data storage media with a coating medium has a rotatable support for the storage medium and at least one coating nozzle comprising a drive unit for moving the at least one coating nozzle across the storage medium to a location of application of the coating medium. The drive unit is a hydraulic arrangement with a first hydraulic cylinder for a first, fast movement and a second hydraulic cylinder for a second, slow movement of the at least one coating nozzle.
Patent IL-147347-A0 (IL)
Title: Channel assignment apparatus and method for common packet channel in a wcdma mobile communication system
IPC: H04W52/50
Filed: 2000-07-07
Abstract: A common packet channel assignment method in a CDMA (Code Division Multiple Access) communication system is disclosed. The method comprises transmitting an access preamble signal having channel information which is used to access a base station; receiving an access preamble acquisition indicator signal received from the base station in response to the access preamble signal; transmitting a collision detection preamble for detecting a collision in response to the received access preamble acquisition indicator signal; receiving a first signal indicating acquisition of the collision detection preamble and a second signal indicating channel assignment, that the base station has transmitted in response to the collision acquisition signal; and upon receipt of the first signal, allocating a common packet channel according to information designated by the second signal. <IMAGE>
Patent IL-149898-A0 (IL)
Title: Butt-ended bag with a buckle-over closing element
IPC: B65D33/16
Filed: 2000-10-20
Abstract: A stand up bag of a heat-sealable or weldable plastic film for receiving liquid and/or paste-like material. The bag includes two side walls connected to each other along their longitudinal edges. A foldable bottom member is positioned between the side walls and serves as a self-standing bottom inserted at the lower end of the stand up bag between lower transverse edges. A foldable cover member is positioned at the upper end of the stand up bag between the side walls and includes a removal opening between the upper transverse edge of a first side wall and the corresponding cover member edge, with a closure element inserted into the removal opening. To be able to empty the stand up bag in a better and simpler way, the closure element is bendable and is retained by a mechanism for stabilizing and retaining the forwardly bent closure element.
Patent IL-150725-A0 (IL)
Title: Treatment of congestive heart failure by pretreated autologous blood
IPC: A61K31/7076
Filed: 2001-01-18
Abstract: A method of treating congestive heart failure (CHF) in a human patient comprises treating an aliquot of the patients blood ex vivo with at least one stressor selected from the group consisting of a temperature above or below body temperature, an electromagnetic emission and an oxidative environment, followed by administering the aliquot of treated blood to the patient. The treatment can be used on its own or as an adjunctive therapy in combination with conventional CHF treatments.
Patent IL-158298-A0 (IL)
Title: Methods and apparatus for electrophoresis of hydratable separation media
IPC: G01N33/561
Filed: 2002-03-18
Abstract: Methods and apparatus are presented that facilitate electrophoresis of prior-cast, hydratable separation media, usefully immobilized pH gradient (IPG) strips. The method exploits the swelling of prior-cast, hydratable separation media upon rehydration to help lodge the media in an enclosing member that permits spaced electrical communication with the enclosed separation media. The electrical communication permits a voltage gradient to be established in the enclosed separation medium sufficient to effect separation of analytes therein. Cassettes, buffer cores, electrophoresis systems and kits are presented for effecting the methods of the invention.
Patent IL-158539-A0 (IL)
Title: Method and apparatus for estimating the position of a terminal based on identification codes for transmission sources
IPC: H04W64/00
Filed: 2002-04-24
Abstract: Techniques to determine the position of a terminal under the coverage of a repeater in a wireless communication system. In an aspect, an identification code is transmitted for each repeater and used by the terminal (or a PDE) to unambiguously identify the repeater. The identification codes for the repeaters in the system can be implemented with PN sequences at defined offsets that are specifically reserved for repeater identification. In another aspect, the identification code for each repeater is transmitted using a spread-spectrum signal designed to have minimal impact on the performance of the system and to be recoverable by the terminal in similar manner as for a forward modulated signal. In this way, no additional hardware is required for the terminal to recover the identifier signal. In one specific design, the spread spectrum identifier signal is generated in accordance with and conforms to the IS-95 CDMA standard.
Patent IL-159681-A0 (IL)
Title: Method for telecommunication, identification module and computerized service unit
IPC: H04W8/06
Filed: 2001-07-18
Abstract: A subscriber, who logs into a visited communication network (VPMN), in particular a mobile network, by means of his communication terminal (2) and his identification module (SIM) connected thereto, is transmitted, automatically or upon request, (S1) a subscriber identification (IMSI-P) from the number range of the visited communication network (VPMN) (S2). The received subscriber identification (IMSI-P) from the number range of the visited communication network (VPMN) is stored and activated in the identification module (SIM) of the subscriber. The subscriber can afterwards log into the visited communication network (VPMN) as a local subscriber.
Patent IL-166442-A0 (IL)
Title: Probiotics for gut neuromuscular functions
IPC: A61P29/00
Filed: 2003-07-23
Abstract: The present invention relates to the use of probiotics in nutritional compositions or medicaments for the prevention or treatment of gut-neuromuscular abnormalities. Such abnormalities are, for example, associated with colic in babies, gut-pain or gut discomfort in general. Probiotics may be administered in a living or dead state, and also the supernatant of fermentation medium may be directly used to achieve the beneficial effects reported herein. <IMAGE>
Patent IL-173350-A0 (IL)
Title: Polyformals as a coextruded protective layer on polycarbonate
IPC: C08L59/00
Filed: 2006-01-25
Abstract: A multi-layer article is disclosed. The article contains a base layer that contains at least one thermoplastic resin and a second layer containing a thermoplastic (co)polyformal superimposed over the base layer. The (co)polyformal conforms to formulae (1a) or (1b), O-D-O-CH2k 1a O-D-O-CH2mOE-O-CH2no 1b in which O-D-O and O-E-O independently denote a diphenolate group, -D- and -E- independently denote an aromatic group having 6 to 40 C atoms, k is a whole number from 1 to 1500 and m is z/o and n is (o-z)/o wherein z is 0 to o. The multi-layer article that may be prepared by co-extrusion exhibits improved properties.
Patent IL-196314-A0 (IL)
Title: Protease screening methods and proteases identified thereby
Filed: 2009-01-01
Abstract: Methods for identifying modified proteases with modified substrate specificity or other properties are provided. The methods screen candidate and modified proteases by contacting them with a substrate, such as a seipin, an alpha macroglobulins or a p35 family protein or modified serpins and modified p35 family members or modified alpha macroglobulins, that, upon cleavage of the substrate, traps the protease by forming a stable complex. Also provided are modified proteases.
Patent IL-232954-A0 (IL)
Title: Antigen binding molecules with increased fc receptor binding affinity and effector function
IPC: C12P21/04
Filed: 2014-06-02
Abstract: The present invention relates to antigen binding molecules (ABMs). In particular embodiments, the present invention relates to recombinant monoclonal antibodies, including chimeric, primatized or humanized antibodies specific for human CD20. In addition, the present invention relates to nucleic acid molecules encoding such ABMs, and vectors and host cells comprising such nucleic acid molecules. The invention further relates to methods for producing the ABMs of the invention, and to methods of using these ABMs in treatment of disease. In addition, the present invention relates to ABMs with modified glycosylation having improved therapeutic properties, including antibodies with increased Fc receptor binding and increased effector function.
Patent RO-127827-A0 (RO)
Title: Process for producing clinker and portland cement with reduced consumption of energy and reduced emission of co
Inventor: PACEAGIU JENICA
IPC: C04B7/02
Filed: 2011-07-26
Abstract: The invention relates to a process for producing a Portland type cement. According to the invention, the process consists in sintering a raw mixture of limestone, fly ashes with a content of 13% coal, finely granulated waste sand and roasted pyrite with up to 0.5% mineralizing CuO, grinding to a fineness of grain expressed as residue of 12% on a sieve of 90 μ mesh width, which is subjected to a heat treatment of 1300...1370°C, followed by rapid fan cooling and subsequent grinding, with maximum 5% addition of setting regulator based on calcium sulphate at a fineness of grain expressed as Blaine specific surface of 3600 cm/g, there resulting a cement with an initial setting time of 60 minutes and a compression strength of 18 MPa after 2 days and of 48MPa after 28 days.
Patent AP-2004003120-A0 (AP)
Title: Combined use of antitumor indolopyrrolocarbazole derivatives and other antitumor agent
Inventor: ARAKAWA HIROHARU
IPC: A61K33/243
Filed: 2002-09-30
Abstract: A combination of pharmaceutical preparations, which are simultaneously, separately, or successively administered in treatments for cancers. It comprises the following two separate preparations: * a pharmaceutical preparation comprising a pharmaceutically acceptable support or diluent and either at least one compound represented by the general formula [I]: [I] (wherein R1 and R2 each independently represents hydrogen, (I) lower alkyl, etc.; G represents a pentose group, etc.; and X1 and X2 each independently represents hydrogen, halogeno, etc.) or a pharmaceutically acceptable salt of the compound and * a pharmaceutical preparation comprising a pharmaceutically acceptable support or diluent and any of an anticancer alkylating agent, anticancer antimetabilite, anticancer antibiotic, plant-derived anticancer agent, and the like (the pharmaceutical preparation containing at least one compound represented by the above formula [I] or a pharmaceutically acceptable salt thereof may be used in combination with two or more other anticancer agents). Also provided is a method of treatments for cancers, characterized by administering these pharmaceutical preparations in combination.
Patent IE-910033-A1 (IE)
Title: Interproximal brush
IPC: A46B3/18
Filed: 1991-01-04
Abstract: An interproximal brush comprises a handle having an end portion provided with a transverse hole communicating with a longitudinal groove for receiving the elongated stem of an interproximal brush. The handle further has a cylindrical boss formed on the lower surface thereof through which the transverse hole extends, and the brush stem is retained securely in the longitudinal groove on closure of a cap, which is pivotably attached to the end portion.
Patent CS-86086-A1 (CS)
Title: Device for shaft turning over
Inventor: VISNIVECKIJ MICHAIL G
IPC: F01D25/34
Filed: 1986-02-07
Abstract: The device comprises an electric drive with a reducing reduction gear connected to a gear wheel (4) mounted on supports (5) and connected to the shaft (6) of an overtaking coupling (7). The supports are in the form of hydrostatic shell bearings. Rotation from the motor is transmitted via the coupling and reduction gear to the gear wheel and then via the overtaking coupling to the shaft. Oil is supplied to the shoes (8) to form an oil film which prevents dry friction.
Patent IE-910531-A1 (IE)
Title: Improvements in and relating to leukotriene antagonists
IPC: A61P11/14
Filed: 1991-02-15
Abstract: This invention provides tricyclic derivatives which are leukotriene B4 antagonists, formulations of those derivatives, and a method of using those derivatives for the treatment of conditions characterized by an excessive release of leukotrienes. The derivatives are of the formula: or a pharmaceutically acceptable base addition salt thereof, wherein Y is -CO-, -C(=NOH)-, -CHOH-, -CH2-, or -C(=CH2)-; A is a bond or -O-; one of R1 and R2 is hydrogen and the other of R1 and R2 is -CH2CH2COOH; p is 1-16; and Z is -H or -G-Q where G is a bond, -O-, -S(O)t-, -NH-, -CH=CH-, or -C IDENTICAL C-, Q is phenyl or phenyl substituted with one or two substituents selected from the group consisting of halo, C1-C3 alkyl, C1-C3 alkoxy, acetyl, nitro, amino, trifluoromethyl, hydroxy, and -S(O)t-(C1-C3 alkyl), and each t is independently 0-2. leu
Patent IE-910596-A1 (IE)
Title: Method for determining the quality properties of individual¹pieces of meat
IPC: G01N33/12
Filed: 1991-02-21
Abstract: The invention relates to a method and an apparatus for the determination of quality properties of individual pieces of meat, e.g. the water-holding capacity or fat marbling, by measuring the intensity of light reflected from the meat surface along a scanning line, to establish a histogram-like set of data relating to the frequency of reflection intensity values, and to calculate one or more characteristic values corresponding to a quality property with use of a suitable mathematical relation, the parameters of which are previously determined. This concept allows a highly accurate and quick determination of meat quality properties and is particularly suited for on-line production and processing of meat.
Patent MA-20552-A1 (MA)
Inventor: MARIEL LEPANT
IPC: C07D213/89
Filed: 1985-10-11
Abstract: Alkylcarboxamides of pyridylalkylamines, useful in human and verterinary medicine, correspond to the general formula I:    <IMAGE> (I)  wherein n=0 or 1, R3 represents an alkyl group of C1 to C3 or a hydrogen atom, R1 represents a hydrogen atom, R2 represents a group: <IMAGE> (II)   in which: X and Y are different, X and Y each represent a linear or branched saturated or unsaturated hydrocarbon chain comprising from 1 to 16 carbon atoms; X and Y together determine a saturated or unsaturated cyclic radical substituted or not comprising from 3 to 12 carbon atoms.
Patent MA-39446-A1 (MA)
Title: Compositions pharmaceutiques pour traiter des maladies infecteuses
Inventor: WASHBURN MICHAEL
IPC: A61P31/16
Filed: 2015-05-08
Abstract: La présente invention concerne des composés et des sels pharmaceutiquement acceptables de ceux-ci, et des associations de composés, leurs compositions pharmaceutiques, leurs procédés de préparation, et leurs procédés d'utilisation dans le traitement ou la prévention d'une maladie infectieuse.
Patent MA-40664-A1 (MA)
Title: Asservissement de centrale solaire thermique à concentration
Inventor: KIRSCHT LUKAS
IPC: F24S23/79
Filed: 2015-12-29
Abstract: L'invention concerne un système de centrale solaire thermique à concentration comportant un réflecteur et un récepteur pour concentrer le rayonnement solaire touchant le réflecteur sur le récepteur, présentant un écran d'ombre et un récepteur d'ombre ainsi qu'un capteur de numérisation de couleur et/ou de luminosité disposé de manière à détecter l'ombre de l'écran d'ombre sur le récepteur d'ombre afin de déterminer un écart entre la position réelle d'ombre et la position de consigne d'ombre et un disposit
Patent UY-27477-A1 (UY)
Title: Formulaciones farmacéuticas
Inventor: DAVIS JOHN DOUGLAS
IPC: A61K9/22
Filed: 2002-10-09
Abstract: Formulación farmacéutica de liberación controlada para administración oral comprendiendo 4-amino-6,7-dimetoxi-2-(5-matanosulfonamido-1,2,3,4-tetrahidroisoquinol-2-il)-5-(2-piridil9quinazolina o sal farmacéuticamente aceptable de ella, y adyuvante, diluyente o vehículo farmacéuticamente aceptable, caracterizada porque la formulación está adaptada para liberar al menos un 50% en peso de la 4-amino-6,7-dimetoxi-2-(5-metanosulfonamido-1,2,3,4-tetrahidro-isoquinol-2-il)-5-(2-piridil)quinazolina, o la sal farmacéuticamente aceptable de la misma, después de 6 horas en Aparato 1 despcrito en Farmacopea de USA 24 (2000), páginas 1941-1943, una velocidad rotacional 100 rpm y medio de disolución constando de 900 ml de ácido clorhídrico 0,01 M conteniendo cloruro sódico al 0,7 % p/v a 37s C.